Mammography

Mammography is a breast imaging technique that uses X-rays to diagnose and locate tumors of the breasts.

Guidance for mammography facilities, state MQSA contract partners, FDA-approved MQSA accreditation bodies and Food and Drug Administration staff

Getty Images

News | Mammography | December 04, 2020
December 4, 2020 — Today, the U.S. Food and Drug Administration (FDA) issued an immediately in effect guidance, ...
Studies show new deep-learning algorithm helps radiologists detect breast cancers in their early stages when used with the Genius 3D Mammography exam
News | Breast Imaging | December 02, 2020
December 2, 2020 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s...
Lunit’s algorithm showed the best performance compared to other commercialized AI algorithms, ultimately reducing the workload of radiologists to classify mammography screenings
News | Artificial Intelligence | December 02, 2020
December 2, 2020 — Recent studies have shown that Lunit’s AI solution is as accurate as average radiologists when it...
Mary C. Mahoney, M.D.

Mary C. Mahoney, M.D.

News | RSNA | December 01, 2020
December 1, 2020 — At the Virtual RSNA 2020 conference, it was announced that Mary C. Mahoney, M.D., is RSNA president...
Researchers developed a deep learning model that identifies imaging biomarkers to predict a patient’s risk for developing breast cancer

A deep learning model was developed that combined imaging and traditional risk factors.

News | Mammography | November 30, 2020
November 30, 2020 — Researchers at Massachusetts General Hospital (MGH) have developed a deep learning model that...
 Lunit, a leading medical AI software company, will be joining the 106th Radiological Society of North America (RSNA) this year, presenting its AI solutions for chest X-ray and mammography at partner booths.
News | Artificial Intelligence | November 24, 2020
November 24, 2020 — Lunit, a leading medical AI software company, will be joining the 106th Radiological Society of...
Densitas Inc., a global provider of A.I. technologies for digital mammography and breast screening, announced its partnership with Mammography Educators to offer the first artificial intelligence powered telehealth technologist training platform to support business continuity in mammography facilities.
News | Mammography | November 20, 2020
November 20, 2020 — Densitas Inc., a global provider of A.I. technologies for digital mammography and breast screening...
Radiologists around the world will have access to a first-of-its-kind online breast density training tool designed to improve radiologists' ability to correctly identify women's breast density categories to comply with the Breast Imaging-Reporting and Data System (BI-RADS), thanks to a collaboration between DetectED-X and Volpara Health. 
News | Breast Density | November 19, 2020
November 19, 2020 — Radiologists around the world will have access to a first-of-its-kind online breast density...
DensitasInc., a leading provider of A.I. technologies for digital mammography and breast screening, announced that NorthShore University HealthSystem (NorthShore), will deploy the densitas  platform across its mammography facilities
News | Breast Imaging | November 16, 2020
November 16, 2020 — Densitas Inc., a leading provider of A.I. technologies for digital mammography and breast screening...
Images in a 55-year-old woman with a spiculated mass localized in the upper central quadrant (arrow in A, B, D, and E) of right breast detected with digital breast tomosynthesis (DBT) plus synthetic mammography (SM). Breast density was classified as category C with the Breast Imaging Reporting and Data System. Mass was invasive ductal carcinoma, stage I, and was estrogen and progesterone receptor positive and human epidermal growth factor receptor 2 negative. A, Image from SM in craniocaudal view. B, Single

Images in a 55-year-old woman with a spiculated mass localized in the upper central quadrant (arrow in A, B, D, and E) of right breast detected with digital breast tomosynthesis (DBT) plus synthetic mammography (SM). Breast density was classified as category C with the Breast Imaging Reporting and Data System. Mass was invasive ductal carcinoma, stage I, and was estrogen and progesterone receptor positive and human epidermal growth factor receptor 2 negative. A, Image from SM in craniocaudal view. B, Single-slice DBT image in craniocaudal view. C, Magnification of the lesion depicted in B. D, Image from SM in mediolateral oblique view. E, Single-slice DBT image in mediolateral oblique view. F, Magnification of the lesion depicted in E. Images courtesy of Radiological Society of North America

News | Breast Imaging | November 11, 2020
November 11, 2020 — Digital breast tomosynthesis (DBT), in combination with synthetic mammography, improves cancer...
Hologic, Inc. announced innovative updates to its Unifi Analytics platform, a breakthrough business intelligence tool that provides mammography centers insights into technologist performance, proactive device maintenance, and business considerations.
News | Mammography | November 10, 2020
November 10, 2020 — Hologic, Inc. announced innovative updates to its Unifi Analytics platform, a breakthrough business...
Honoring essential healthcareprofessionals, Nov. 8-14
News | Radiology Imaging | November 09, 2020
November 9, 2020 — As COVID-19 continues to spread in communities throughout the country, Americans rely on radiologic...
Mammograms in a 51-year-old woman with invasive ductal carcinoma. The upper panels show the craniocaudal and the mediolateral oblique views. The lower panels show a close-up of the left breast area containing the lesion. The case is one of the false-negative cases included in the dataset. Accordingly, the initial screening assessment was a BI-RADS 2, meaning visible findings were judged as benign. After 1 year, the patient presented for another screening examination. This time, a focal asymmetry with associ

Mammograms in a 51-year-old woman with invasive ductal carcinoma. The upper panels show the craniocaudal and the mediolateral oblique views. The lower panels show a close-up of the left breast area containing the lesion. The case is one of the false-negative cases included in the dataset. Accordingly, the initial screening assessment was a BI-RADS 2, meaning visible findings were judged as benign. After 1 year, the patient presented for another screening examination. This time, a focal asymmetry with associated distortion within the left breast was noticed; the patient was recalled and diagnosed with a 1.5-cm mass in the upper outer quadrant of the left breast on the craniocaudal view (circle).

News | Mammography | November 04, 2020
November 4, 2020 — Artificial intelligence (AI) can enhance the performance of radiologists in reading breast cancer...
Innovation can help address screening backlog due to COVID-19 pandemic by streamlining breast imaging reading process
News | Breast Imaging | November 02, 2020
November 2, 2020 — Hologic, Inc. announced the commercial availability in Europe of its 3DQuorum Imaging Technology,...
Murray Rebner, M.D., performing a breast ultrasound. Image courtesy of Beaumont Health

Murray Rebner, M.D., performing a breast ultrasound. Image courtesy of Beaumont Health

News | Breast Imaging | November 02, 2020
November 2, 2020 — Though Black women get breast cancer at a 3% lower incidence rate than white women, they are 42%...
Culturally relevant strategies are necessary to improve preventive health care in this rapidly growing population, Rutgers researchers say

Getty Images

News | Women's Health | October 28, 2020
October 28, 2020 — Indian and Pakistani women are diagnosed with breast cancer, including more aggressive forms of the...
Study of Penn Medicine patients shows abbreviated MRI may be a valuable supplemental screening for women with dense breasts
News | MRI Breast | October 28, 2020
October 28, 2020 — Beth Reisboard, 76, was relieved in 2018 when she received the results from her annual mammogram: “...
Mammography, which is an X-ray picture of the breast, is efficient also for women over the age of 70.

Getty Images

News | Mammography | October 22, 2020
October 22, 2020 — Mammography, which is an X-ray picture of the breast, is efficient also for women over the age of 70...
Rebrand reflects Volpara Health's mission to prevent advanced-stage breast cancer
News | Breast Imaging | October 19, 2020
October 19, 2020 — Volpara Solutions, a leader in AI-powered breast density assessment, announced that it has changed...
Fujifilm Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, and Volpara Solutions, a purpose-driven software company on a mission to prevent advanced-stage breast cancer, today announced an expanded partnership to provide mammography facilities and clinicians with breast imaging solutions designed to improve image quality, streamline workflow and accurately assess a patient's breast density.
News | Breast Imaging | October 15, 2020
October 15, 2020 — Fujifilm Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical...